White Wendy M, Mielke Michelle M, Araoz Philip A, Lahr Brian D, Bailey Kent R, Jayachandran Muthuvel, Miller Virginia M, Garovic Vesna D
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN.
Department of Health Science Research and Neurology, Mayo Clinic, Rochester, MN.
Am J Obstet Gynecol. 2016 Apr;214(4):519.e1-519.e8. doi: 10.1016/j.ajog.2016.02.003. Epub 2016 Feb 10.
A history of preeclampsia is an independent risk factor for cardiac events and stroke. Changes in vasculature structure that contribute to these associations are not well understood.
The aim of this study was to quantify coronary artery calcification (CAC), a known risk factor for cardiac events, in a prospective cohort of women with and without histories of preeclampsia.
Women without prior cardiovascular events (40 with and 40 without histories of preeclampsia, matched for parity and age at index birth) were recruited from a large population-based cohort of women who were residents of Olmsted County, Minnesota, and who delivered from 1976 through 1982. Computed tomography was performed to measure CAC in Agatston units. All pregnancy histories and covariates were confirmed by review of the medical records. Current clinical variables were assessed at the time of imaging. Differences between women with and without histories of preeclampsia were examined using χ(2) tests and tests; CAC, in particular, was compared as a categorical and ordinal variable, with a χ(2) test and with Wilcoxon 2-sample tests and ordinal logistic regression, as appropriate.
Mean age (SD) at imaging was 59.5 (±4.6) years. Systolic and diastolic blood pressures, hyperlipidemia, and current diabetes status did not differ between women with and without histories of preeclampsia. However, the frequencies of having a current clinical diagnosis of hypertension (60% vs 20%, P < .001) and higher body mass index in kg/m(2) (expressed as median [25th-75th percentile], 29.8 [25.9-33.7] vs 25.3 [23.1-32.0], P = .023) were both greater in the women with histories of preeclampsia compared to those without. The frequency of a CAC score >50 Agatston units was also greater in the preeclampsia group (23% vs 0%, P = .001). Compared to women without preeclampsia, the odds of having a higher CAC score was 3.54 (confidence interval [CI], 1.39-9.02) times greater in women with prior preeclampsia without adjustment, and 2.61 (CI, 0.95-7.14) times greater after adjustment for current hypertension. After adjustment for body mass index alone, the odds of having a higher CAC based on a history of preeclampsia remained significant at 3.20 (CI, 1.21-8.49).
In this first prospective cohort study with confirmation of preeclampsia by medical record review, a history of preeclampsia is associated with an increased risk of CAC >30 years after affected pregnancies, even after controlling individually for traditional risk factors. A history of preeclampsia should be considered in risk assessment when initiating primary prevention strategies to reduce cardiovascular disease in women. Among women with histories of preeclampsia, the presence of CAC may be able to identify those at a particularly high cardiovascular risk, and should be the subject of future studies.
子痫前期病史是心脏事件和中风的独立危险因素。导致这些关联的血管结构变化尚不清楚。
本研究的目的是在前瞻性队列中,对有和无子痫前期病史的女性进行冠状动脉钙化(CAC)定量分析,冠状动脉钙化是已知的心脏事件危险因素。
从明尼苏达州奥尔姆斯特德县的一大群女性中招募无既往心血管事件的女性(40名有子痫前期病史,40名无子痫前期病史,根据产次和首次分娩时的年龄进行匹配),这些女性于1976年至1982年分娩。采用计算机断层扫描以阿加西单位测量CAC。通过查阅病历确认所有妊娠史和协变量。在成像时评估当前临床变量。采用χ²检验和检验来检查有和无子痫前期病史女性之间的差异;特别是将CAC作为分类变量和有序变量进行比较,酌情采用χ²检验、Wilcoxon两样本检验和有序逻辑回归。
成像时的平均年龄(标准差)为59.5(±4.6)岁。有和无子痫前期病史的女性在收缩压和舒张压、高脂血症及当前糖尿病状态方面无差异。然而,有子痫前期病史的女性当前临床诊断为高血压的频率(60% 对20%,P <.001)以及以kg/m²为单位的较高体重指数(表示为中位数[第25 - 75百分位数],29.8 [25.9 - 33.7] 对25.3 [23.1 - 32.0],P =.023)均高于无该病史的女性。子痫前期组中CAC评分>50阿加西单位的频率也更高(23% 对0%,P =.001)。与无子痫前期的女性相比,有子痫前期病史的女性在未调整时CAC评分较高的几率高3.54倍(置信区间[CI],1.39 - 9.02),在调整当前高血压后高2.61倍(CI,0.95 - 7.14)。仅调整体重指数后,基于子痫前期病史CAC较高的几率仍显著,为3.20(CI,1.21 - 8.49)。
在这项通过病历审查确诊子痫前期的首个前瞻性队列研究中,子痫前期病史与受影响妊娠30多年后CAC风险增加相关,即使单独控制传统危险因素后也是如此。在启动预防女性心血管疾病的一级预防策略进行风险评估时,应考虑子痫前期病史。在有子痫前期病史的女性中,CAC的存在可能能够识别出心血管风险特别高的人群,应成为未来研究的主题。